Reproductive Health | ENDO 2022 Press Conference

Rate:
5
5 5 1
added:
4 weeks ago
views:
231
specialty:
Endocrinology

Case description

The ENDO 2022 News Conference on Reproductive Health


Researchers will discuss the COVID-19 pandemic stresses impact on women’s ovulatory cycles, the results of the year-long phase 3 study on hot flash medication fezolinetant, the economic costs of treating mental health disorders in women with polycystic ovary syndrome, and a mouse model of in vitro fertilization in transgender men active testosterone treatment.


Presenters: Jerilynn C. Prior, MD, FRCPC Amanda Schwartz, MD Genevieve Neal-Perry, MD, PhD Ricardo Azziz, MD, MPH, MBA 

tags: reproductive system fezolinetant reproductive health


Natalia Dułak
Editor

Natalia Dułak

MD

This user also sharing

Recommended

show more